Eczema flares on psoriasis biologics: how often, and which drugs carry more risk
A meta-analysis published Oct. 16, 2026, in BioDrugs found that 2.17% of people treated with biologics for psoriasis developed eczema-like reactions, most often with IL-17 inhibitors and least with IL-23 inhibitors.